Literature DB >> 12698068

What is the most important component of blood pressure: systolic, diastolic or pulse pressure?

Timo E Strandberg1, Kaisu Pitkala.   

Abstract

PURPOSE OF REVIEW: Diastolic blood pressure has traditionally been considered the most important component of blood pressure and the primary target of antihypertensive therapy. However, over 30 years ago important epidemiological studies pointed out the importance of systolic blood pressure, and research during the 1990s has strengthened this view. Unlike diastolic blood pressure, systolic blood pressure increases progressively with age, and in the ageing societies elevated systolic pressure is the most common form of hypertension. The characteristic changes of systolic and diastolic blood pressure with age lead to increases in pulse pressure (systolic minus diastolic), which has emerged as a new, potentially independent risk factor. In this review we compare the relative importance of various blood pressure components. RECENT
FINDINGS: Generally, in studies in which readings of systolic and diastolic blood pressure have been compared, systolic blood pressure has been a better predictor of risk. Moreover, isolated systolic hypertension predicts risk better than isolated diastolic hypertension, and the treatment of both isolated systolic hypertension and combined hypertension has reduced cardiovascular events. There are no treatment studies of isolated diastolic hypertension. Pulse pressure reflects stiffening of large arteries and is associated with several cardiovascular risk factors. Pulse pressure also predicts events in epidemiologic studies, but elucidation of an independent role is hampered by the close correlation between pulse pressure and systolic blood pressure.
SUMMARY: Epidemiological and treatment studies suggest that systolic blood pressure should be the primary target of antihypertensive therapy, although consideration of systolic and diastolic pressure together improves risk prediction. The greatest practical concern at the moment is the undertreatment of hypertension, especially systolic, and total cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12698068     DOI: 10.1097/00041552-200305000-00011

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  62 in total

Review 1.  Systolic pressure, diastolic pressure, or pulse pressure as a cardiovascular risk factor in renal disease.

Authors:  José A García-Donaire; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

2.  Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder.

Authors:  Katie Witkiewitz; Henry R Kranzler; Kevin A Hallgren; Stephanie S O'Malley; Daniel E Falk; Raye Z Litten; Deborah S Hasin; Karl F Mann; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2018-11-05       Impact factor: 3.455

3.  Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study.

Authors:  S Rasmussen; N Borrild; J Vang Andersen
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

4.  Cardiac vagal control mediates the relation between past depression and blood pressure several years later among young adults.

Authors:  Xiao Yang; Shimrit Daches; Ilya Yaroslavsky; Charles J George; Maria Kovacs
Journal:  Psychophysiology       Date:  2020-01-27       Impact factor: 4.016

5.  Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012.

Authors:  Omayma Alshaarawy; Hosam A Elbaz
Journal:  J Hypertens       Date:  2016-08       Impact factor: 4.844

6.  Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America.

Authors:  Rodrigo M Carrillo-Larco; J Jaime Miranda; Xian Li; Chendi Cui; Xiaolin Xu; Mohammed Ali; Dewan S Alam; Thomas A Gaziano; Rajeev Gupta; Vilma Irazola; Naomi S Levitt; Dorairaj Prabhakaran; Adolfo Rubinstein; Krisela Steyn; Nikhil Tandon; Denis Xavier; Yangfeng Wu; Lijing L Yan
Journal:  Glob Heart       Date:  2016-03

7.  "We get what we deserve": the belief in a just world and its health consequences for Blacks.

Authors:  Nao Hagiwara; Courtney J Alderson; Jessica M McCauley
Journal:  J Behav Med       Date:  2015-06-28

8.  Open-label randomized trial of titrated disease management for patients with hypertension: Study design and baseline sample characteristics.

Authors:  George L Jackson; Morris Weinberger; Miriam A Kirshner; Karen M Stechuchak; Stephanie D Melnyk; Hayden B Bosworth; Cynthia J Coffman; Brian Neelon; Courtney Van Houtven; Pamela W Gentry; Isis J Morris; Cynthia M Rose; Jennifer P Taylor; Carrie L May; Byungjoo Han; Christi Wainwright; Aviel Alkon; Lesa Powell; David Edelman
Journal:  Contemp Clin Trials       Date:  2016-07-12       Impact factor: 2.226

Review 9.  Is Chinese herbal medicine effective for elderly isolated systolic hypertension? A systematic review and meta-analysis.

Authors:  Yu Cao; Long-Tao Liu; Min Wu
Journal:  Chin J Integr Med       Date:  2016-05-25       Impact factor: 1.978

Review 10.  Pulse pressure as an independent predictor of stroke: a systematic review and a meta-analysis.

Authors:  Feng-Di Liu; Xiao-Lei Shen; Rong Zhao; Xiao-Xiao Tao; Shuo Wang; Jia-Jun Zhou; Bo Zheng; Qi-Ting Zhang; Qian Yao; Ying Zhao; Xin Zhang; Xue-Mei Wang; Hui-Qin Liu; Liang Shu; Jian-Ren Liu
Journal:  Clin Res Cardiol       Date:  2016-02-22       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.